French health officials received dozens of reports of syringe pricks at a public festival, sparking fear about HIV and ...

A breakthrough to reduce risk of HIV in adolescents and adults weighing at least 35 kg. WHO releases the new guidelines ...

The World Health Organization has approved the rollout of an injectable HIV preventive drug; Lenacapavir or LEN. The National ...

The World Health Organization now recommends lenacapavir, a twice-yearly injectable HIV prevention drug, especially for high-risk groups. This endorsement arrives amidst funding concerns, with Gilead ...

We’ve come a long way in treating HIV, the virus that can lead to AIDs. Just last month, the FDA approved a medication that ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

USPS changes stamp prices: What to know New Jersey woman nearly dies after taking dangerous amount of popular supplement: ‘I ...

The WHO’s 2025 policy brief highlights how tuberculosis disproportionately affects marginalized and high-risk populations due ...

The proposed cuts have caused concerns among some Senate Republicans, including Utah Sen. John Curtis, who may consider ...

As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...

Alarice Marsh, M.P.H., a deputy director in the National Department of Health of South Africa and program lead of HIV testing ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.